Welcome Stockaholics!

We are a new and fast growing financial forum! Sign up for free and let's talk stocks!

  1. Do you want to help develop this community? We are looking for contributions from investors and traders like you! What stocks do you follow? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing financial forum!
    Dismiss Notice
  2. You will notice a live chat widget on the right. Click in to join us and lets hear about how you nailed that last UWTI trade!
    Dismiss Notice

Investing in Psychedelics: Mind Medicine

Discussion in 'Penny Stocks' started by Benji, Mar 26, 2020 at 5:45 PM.

  1. Benji

    Benji New Member

    Likes Received:
    When the world’s first pure play publicly listed psychedelic medicine company – Mind Medicine Inc. (MMED:NEO – NEO is a Canadian exchange) listed in early March, the stock soared.

    It was up 300% in its first three days of trading. Of course, the Market crash in the last few days has brought the stock down. But it’s a very encouraging early sign of investor interest…in what some believe will be the next stock market bubble.

    They announced TODAY that they are starting human trials on one of their products that they are hoping will be a cure for opioid addiction, and the stock is up 30% on volume.

    Several very astute investors—like Steve Cohen and Peter Thiel—have placed large bets in the psychedelics space.

    There have been some encouraging indications that psychedelics DO work as a medicine (=high efficacy).

    It reminds me of the monster returns generated by early investors in the cannabis space. Consider early cannabis industry entrant Canopy Growth (WEED:TSX) for instance:

    Rest of the story is here: https://investingwhisperer.com/investing-in-psychedelics/

Share This Page